Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

6661 WELGENE

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

CHEN KUEI HUNG

YI SHING LIN

CHEN YING JEN

(02)66160001

12F., No.3, Park St., Nangang Dist.,Taipei City 115, Taiwan (R.O.C.)

2021/01/27

Industry

Main Business

Biotechnology and Medical Care

The R&D strategy of Welgene Biotech. has always being on the high-throughput technology platforms such as microarray and next generation sequencing and drive these technologies into clinical testing or commodities, including array-based CGH for the chromosomal aberrations, embryo implantation (Preimpantation Genetic Screening Array, PGS array) and Non-Invasive Prenatal Test (NIPT). Welgene continues to co-work with researchers to look forward to establishing more core technologies and products and developing business opportunities.

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2023/09/22 )
4.013	22.70	22.70	22.70	-0.35	5		N/A	N/A
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2023/09/22)	TPEx measures adopted (2023/09/22)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		N	N	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile